<DOC>
	<DOCNO>NCT00214578</DOCNO>
	<brief_summary>The purpose study determine whether six month treatment antipsychotic medicine Seroquel ( quetiapine ) may affect schizophrenic patient 's glucose metabolism</brief_summary>
	<brief_title>Seroquel Glucose Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>In outpatient schizophrenia , 1865 year old , require change treatment due insufficient efficacy tolerability give sign informed consent . Known diabetes mellitus , high HbA1c , fast plasma glucose and/or high 2h glucoseOGTT . Previous use atypicals ( 3 month ) medication might influence glucose metabolism Contraindications nonresponsiveness treatment safety issue Expected noncompliance treatment and/or study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>